ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

QT prolongation QT prolongation has been observed in patients treated with delamanid. This prolongation increases slowly over time in the first 6 to 10 weeks of treatment and remains stable therafter. QTc prolongation is very closely correlated with the major delamanid metabolite DM -6705. Plasma albumin and

  Prolongation, Qtc prolongation